Clinical Trials Search

Use this page to search all trials that are open to enrollment for adult and pediatric patients. For more information on clinical trials at Sanford Health, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890; and Sioux Falls Clinical Research at (605) 328-1388. You can also learn more by visiting clinicaltrials.gov, which is a comprehensive national registry of all clinical trials.

Cancer
Assessment of Patient Satisfaction with Participation in NCCTG Clinical Trials
Study ID: NCCTG N0392
Disease: Other
Stage: Unknown
  Learn More
Phase III Trial of Post-Surgical Stereotactic Radiosurgery Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
Study ID: CTSU N107C
Disease: Brain and Nervous System
Stage: Phase III
  Learn More
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
Study ID: CTSU A011104/ACRIN 6694
Disease: Breast - Invasive
Stage: N/A
  Learn More
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Study ID: CTSU A011202
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer
Study ID: ECOG E2112
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A randomized, double-blind, placebo-controlled, Phase 3 study of fulvestrant with or without LY2835219, a CDK4/6 inhibitor, for post-menopausal women with hormone receptor positive, HER2 negative metastatic breast cancer and disease progression after prior endocrine therapy
Study ID: Lilly I3Y-MC-JPBL Breast
Disease: Breast - Invasive
Stage: Phase III
  Learn More
Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma in Situ Resected by Lumpectomy
Study ID: NSABP B-43
Disease: DCIS, Cancer Control
Stage: Phase III
  Learn More
Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
Study ID: NSABP B-47
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Study ID: NSABP B-51
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated with Neoadjuvant Therapy of Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab (TCHP) With or Without Estrogen Deprivation
Study ID: NSABP B-52
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL-GROUP PHASE 2 STUDY OF THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RTA 408 LOTION IN THE TREATMENT OF PATIENTS AT RISK FOR RADIATION DERMATITIS
Study ID: Reata Radiation Dermatitis 408-C-1306
Disease: Breast - Invasive
Stage: Unknown
  Learn More
A Randomized, Multicenter, Open-Label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine versus Trastuzumab as Adjuvant Therapy for Patients with HER2-Positive Primary Breast Cancer who have Residual Tumor Present Pathologically in the Breast or Axillary Lymph Nodes Following Preoperative Therapy
Study ID: Roche BO27938 / NSABP B-50-I / GBG 77 (KATHERINE) Trial
Disease: Breast - Invasive
Stage: Phase III
  Learn More
Nutrition Coaching for Breast Cancer Patients Undergoing Treatment to Decrease Insulin Resistance
Study ID: SH Nutrition Coaching for Breast Cancer Terstriep
Disease: Other
Stage: Pilot/Feasibility
  Learn More
A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer
Study ID: CTSU S1202
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Study ID: ECOG E1Z11
Disease: Cancer Control
Stage: N/A
  Learn More
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Randomized, Double-Blind, Placebo-Controlled Trial
Study ID: CTSU A221301
Disease: Cancer Prevention
Stage: N/A
  Learn More
Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Study ID: CTSU C80702
Disease: Colon
Stage: Phase III
  Learn More
Randomized Phase II Trial Of Pet Scan-Directed Combined Modality Therapy In Esophageal Cancer
Study ID: CTSU C80803
Disease: Esophagus
Stage: Phase II
  Learn More
Double-Blind Placebo-Controlled Trial of Elfornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III
Study ID: CTSU S0820
Disease: Colorectal
Stage: Phase III
  Learn More
Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric, or Gastroesophageal Junction (GEJ) Cancer
Study ID: CTSU S1201
Disease: Esophagus, GE Junction, Stomach
Stage: Phase II
  Learn More
NSABP Patient Registry and Biospecimen Profiling Repository
Study ID: NSABP MPR-1
Disease: Colorectal
Stage: Unknown
  Learn More
AN OPEN-LABEL, MULTI-CENTER, RANDOMIZED PHASE 1B/2 STUDY OF PF-05212384 PLUS 5-FLUOROURACIL-LEUCOVORIN-IRINOTECAN (FOLFIRI) VERSUS BEVACIZUMAB PLUS FOLFIRI IN METASTATIC COLORECTAL CANCER
Study ID: Pfizer B2151007
Disease: Colorectal
Stage: Phase I/II
  Learn More
A Phase III Trial of Enzalutamide (NSC#766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
Study ID: CTSU A031201
Disease: Prostate
Stage: Phase III
  Learn More
Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) with Commercially Supplied Sunitinib in Patients with Previously Untreated Metastatic Renal Cell Carcinoma
Study ID: CTSU A031203
Disease: REN (Renal)
Stage: Phase II
  Learn More
Randomized Double-Blind Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Study ID: CTSU C90601
Disease: Bladder
Stage: Phase III
  Learn More
Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
Study ID: CTSU R0534
Disease: Prostate
Stage: Phase III
  Learn More
Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
Study ID: CTSU R0815
Disease: Prostate
Stage: Phase III
  Learn More
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Study ID: CTSU R0924
Disease: Prostate
Stage: Phase III
  Learn More
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study.
Study ID: CTSU S0931
Disease: REN (Renal)
Stage: Phase III
  Learn More
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Study ID: CTSU S1216
Disease: Prostate
Stage: Phase III
  Learn More
A Randomized Phase III Study of Standard VS IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Study ID: CTSU R1203
Disease: Cervix, Endometrial
Stage: Phase III
  Learn More
Randomized controlled study comparing AEZS-108 with doxorubicin as second line therapy for locally advanced, recurrent or metastatic endometrial cancer
Study ID: Ergomed AEZS-108-050 Advanced Endometrial Ca
Disease: Endometrial
Stage: Phase III
  Learn More
Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (Or Gemcitabine) Alone or in Combination with Bevacizumab (NSC #704865, IND #113912) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Fallopian Tube and Peritoneal Primary Cancer
Study ID: GOG 0213
Disease: Ovary/Fallopian Tube/Primary Peritoneal
Stage: Phase III
  Learn More
Can Diet and Physical Activity Modulate Ovarian or Primary Peritoneal Cancer Progression-Free Survival?
Study ID: GOG 0225
Disease: Ovary/Fallopian Tube/Primary Peritoneal
Stage: N/A
  Learn More
A Novel Method of Screening for Ovarian Cancer using Gynecologic Fluids and Mucus
Study ID: Univ of S Alabama USA-MCI GON-1.01 Ovarian Cancer Screening
Disease: Ovary/Fallopian Tube/Primary Peritoneal
Stage: Phase II
  Learn More
Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer
Study ID: CTSU R0920
Disease: Head & Neck
Stage: Phase III
  Learn More
A Phase II Clinical Trial of Single Agent Pembrolizumab (MK-3475) in Subjects with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Who Have Failed Platinum and Cetuximab
Study ID: Merck 3475 Keynote 55 (H & N)
Disease: Head & Neck
Stage: Phase II
  Learn More
Understanding and Improving Treatment of Head and Neck Cancer
Study ID: SH Understanding and Improving Treatment of Head and Neck Cancer
Disease:
Stage: N/A
  Learn More
A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (>/= 65 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
Study ID: CTSU A041202
Disease: Hematologic, Other
Stage: Phase III
  Learn More
Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL)
Study ID: CTSU S1001
Disease: NHL (Non-Hodgkins Lymphoma)
Stage: Phase II
  Learn More
Randomized Phase II Study of Lenalidomide R-CHOP (R2CHOP) vs R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) in Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma
Study ID: ECOG E1412
Disease: NHL (Non-Hodgkins Lymphoma)
Stage: Phase II
  Learn More
A Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)
Study ID: ECOG E1912
Disease: HEME (Hemetologic)
Stage: Phase III
  Learn More
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Study ID: ECOG E2906
Disease: AML (Acute Myelogenic Leukemia)
Stage: Phase III
  Learn More
A Compassionate Use Open-Label Study of Anti IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome
Study ID: GSK MHE104317
Disease: HEME (Hemetologic)
Stage: Unknown
  Learn More
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Study ID: Alliance A081105
Disease: Lung
Stage: N/A
  Learn More
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Study ID: Alliance A151216
Disease: Lung
Stage: N/A
  Learn More
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin or Carboplatin and Etoposide
Study ID: CTSU C30610
Disease: Small Cell Lung Cancer
Stage: Phase III
  Learn More
Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
Study ID: CTSU S1400
Disease: Lung
Stage: Phase II/III
  Learn More
Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination with Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer
Study ID: ECOG E2511
Disease: Small Cell Lung Cancer
Stage: Phase I/II
  Learn More
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Study ID: ECOG E5508
Disease: Non-Small Cell Lung Cancer
Stage: Phase III
  Learn More
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Study ID: ECOG-ACRIN E4512
Disease: Lung
Stage: Phase III
  Learn More
A Phase II, Non-comparative, Open label, Multi-centre, International Study of MEDI4736, in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have received at least Two Prior Systemic Treatment Regimens Including One Platinum-based Chemotherapy Regimen (ATLANTIC)
Study ID: Quintiles Astra Zeneca Atlantic D4191C00003
Disease: Lung
Stage: Phase II
  Learn More
A Phase III randomized, 3-arm, open label, multicenter study of LGX818 plus MEK162 and LGX818 monotherapy compared with vemurafenib in patients with unresectable or metastatic BRAF V600 mutant melanoma
Study ID: Novartis Columbus CMEK162B2301 Melanoma
Disease: Melanoma
Stage: Phase III
  Learn More
Randomized Phase II Study of Maintenance Pemetrexed versus Observation for Patients with Malignant Pleural Mesothelioma Without Progression after First-Line Chmeotherapy
Study ID: CTSU C30901
Disease: Mesothelioma
Stage: Phase II
  Learn More
A Phase II Randomized Study Comparing Two Doses of Carfilzomib (NSC-756640) with Dexamethasone for Multiple Myeloma Patients with Relapsed or Refractory
Study ID: CTSU S1304
Disease: Multiple Myeloma
Stage: Phase II
  Learn More
Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Study ID: ECOG E1A11
Disease: Multiple Myeloma
Stage: Phase III
  Learn More
MY PATHWAY: AN OPEN-LABEL PHASE IIA STUDY EVALUATING TRASTUZUMAB/PERTUZUMAB, ERLOTINIB, VEMURAFENIB, AND VISMODEGIB IN PATIENTS WHO HAVE ADVANCED SOLID TUMORS WITH MUTATIONS OR GENE EXPRESSION ABNORMALITIES PREDICTIVE OF RESPONSE TO ONE OF THESE AGENTS
Study ID: Genentech ML28897/PRO 02 MY PATHWAY
Disease: Other
Stage: Phase IIA
  Learn More
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 1 - BKM120 for patients with PI3K-activated tumors
Study ID: Novartis CBKM120ZUS40 Signature
Disease: Other
Stage: Phase II
  Learn More
Modular Phase II Study to Link Targeted Therapy to Patients with pathway Activated tumors: Module 5 - LDE225 for patients with PTCH1 and SMO mutated tumors
Study ID: Novartis CLDE225XUS20 Signature
Disease: Other
Stage: Phase II
  Learn More
Modular phase II study to link targeted therapy to patients with pathway activated tumors:Module 8 ¿ LEE011 for patients with CDK4/6 pathway activated tumors
Study ID: Novartis CLEE011XUS03 Signature
Disease: Other
Stage: Phase II
  Learn More
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 4 - LGX818 for patients with BRAFV600 mutated tumors
Study ID: Novartis CLGX818AUS03 Signature
Disease:
Stage: Phase II
  Learn More
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 3- MEK162 for patients with RAS/RAF/MEK activated tumors
Study ID: Novartis CMEK162AUS11 Signature
Disease: Breast - Invasive, Other
Stage: Phase II
  Learn More
Determine the feasability of including newly recognized metrics to measure the efficacy of Patient Navigation
Study ID: SH ACS Navigation Study
Disease:
Stage: Unknown
  Learn More
Genetic Exploration of the Molecular Basis of Malignancy in Adults
Study ID: SH GEMMA
Disease:
Stage: Pilot/Feasibility
  Learn More
Children's
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
Study ID: COG ACNS02B3
Disease: CNS (Brain Tumors)
Stage: Unknown
  Learn More
Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
Study ID: COG ACNS0332
Disease: CNS (Brain Tumors)
Stage: Phase III
  Learn More
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years
Study ID: COG ACNS0831
Disease: CNS (Brain Tumors)
Stage: Phase III
  Learn More
Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLA-BSI) and Acquisition of Multi-Drug Resistant Organisms (MDRO) in Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplnation (HCT)
Study ID: COG ACCL1034
Disease: AML (Acute Myelogenic Leukemia), Cancer Control, HEME (Hemetologic), CCL, SCT (Stem Cell Transplantation)
Stage: Phase III
  Learn More
MPS VI Clinical Surveillance Program
Study ID: BioMarin MPS VI CSP
Disease: Other
Stage: Post Marketing
  Learn More
A Global, Multi-Center, Long-Term, Observational Survey of Patients with Hunter Syndrome (Mucopolysaccharidosis II)
Study ID: Shire HOS (hunter)
Disease: Other
Stage: Unknown
  Learn More
Pilot study to clarify and finalize EMG protocol in neonates with dysphagia
Study ID: SH EMG Pilot Khan
Disease: Esophagus, Head & Neck
Stage: N/A
  Learn More
Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Study ID: SH NMES for Dysphagia in Neonates Khan
Disease: Esophagus, Head & Neck
Stage: Unknown
  Learn More
My Life Our Future: A Hemophilia Genotyping Initiative Data and Sample Research Repository
Study ID: Biogen My Life Our Future: A Hemophilia Genotyping Initiative
Disease: HEME (Hemetologic)
Stage: N/A
  Learn More
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Study ID: COG AALL05B1
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Unknown
  Learn More
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Study ID: COG AALL08B1
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Unknown
  Learn More
Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
Study ID: COG AALL0932
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Phase III
  Learn More
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum: A Groupwide Phase III Study
Study ID: COG AALL1131
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Phase III
  Learn More
Risk Adapted Treatment of Newly Diagnosed Childhood Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide (Trisenox, IND#103,331) during Consolidation
Study ID: COG AAML0631
Disease: APL
Stage: Phase III
  Learn More
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Study ID: COG AAML08B1
Disease: AML (Acute Myelogenic Leukemia)
Stage: Unknown
  Learn More
A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443, NSC# 681239) and Sorafenib (BAY 43-9006, IND#69896,NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD.
Study ID: COG AAML1031
Disease: AML (Acute Myelogenic Leukemia)
Stage: Phase II/III
  Learn More
A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Study ID: COG ACCL0933
Disease: AML (Acute Myelogenic Leukemia), CCL
Stage: Phase III
  Learn More
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Study ID: COG ACCL0934
Disease: ALL (Acute Lymphocytic Leukemia), AML (Acute Myelogenic Leukemia), CCL
Stage: Phase III
  Learn More
A Randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, commercially labeled) in Combination with Chemotherapy for Newly Diagnosed Patients with Anaplastic Large Cell Lymphoma (ALCL) IND # 117117
Study ID: COG ANHL12P1
Disease: NHL (Non-Hodgkins Lymphoma)
Stage: Phase II
  Learn More
Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) when Exposed to plasma-derived von Willebrand Factor-Containing Factor VIII Concentrates and to Recombinant Factor VIII Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial.
Study ID: SIPPETT Fargo
Disease: Hematologic, Other
Stage: Phase IV
  Learn More
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
Study ID: Seattle Childrens CFFC-OB-11
Disease:
Stage: Unknown
  Learn More
Renal Tumors Classification, Biology, and Banking Study
Study ID: COG AREN03B2
Disease: REN (Renal)
Stage: N/A
  Learn More
Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Study ID: COG ACNS1123
Disease: CNS (Brain Tumors), GCT (Germ Cell Tumor)
Stage: Phase II
  Learn More
Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer
Study ID: COG ALTE07C1
Disease: CNS (Brain Tumors), LTE (Late Effects), CCL
Stage: Unknown
  Learn More
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloblative Therapy and Autologous Stem Cell Rescue
Study ID: COG ANBL0032
Disease: NBL (Neuroblastoma)
Stage: Phase III
  Learn More
Neuroblastoma Biology Studies
Study ID: COG ANBL00B1
Disease: NBL (Neuroblastoma)
Stage: Unknown
  Learn More
A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC# 683864, IND# 61010) or Chimeric 14.18 Antibody (ch14.18) (NSC# 623408, IND# 4308) in Children with Refractory, Relapsed or Progressive Neuroblastoma
Study ID: COG ANBL1221
Disease: NBL (Neuroblastoma)
Stage: Phase II
  Learn More
VTTP A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients with Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
Study ID: VTPP JSPP-12-01 Point Prevalence Study of Antibodies to Selected Porcine Viruses
Disease:
Stage: N/A
  Learn More
A Children's Oncology Group Protocol for COllecting and Banking Ewing Sacroma Specimens
Study ID: COG AEWS07B1
Disease: EWS (Ewing Sarcoma)
Stage: Unknown
  Learn More
A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma.
Study ID: COG AEWS1031
Disease: EWS (Ewing Sarcoma)
Stage: Phase III
  Learn More
A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
Study ID: COG AOST06B1
Disease: OST (Osteosarcoma)
Stage: Unknown
  Learn More
A Phase II Study of Eribulin (IND# 122686, NSC# 707389) in Recurrent or Refractory Osteosarcoma
Study ID: COG AOST1322
Disease: OST (Osteosarcoma)
Stage: Phase II
  Learn More
A COG Soft Tissue Sarcoma Biology and Banking Protocol
Study ID: COG D9902
Disease: RST (Soft Tissue Sarcoma)
Stage: Unknown
  Learn More
Key Adverse Events after Childhood Cancer
Study ID: COG ALTE03N1
Disease: LTE (Late Effects)
Stage: Unknown
  Learn More
Hodgkin Disease Banking Study
Study ID: COG AHOD04B1
Disease: HOD (Hodgkin Disease)
Stage: Unknown
  Learn More
Umbrella Long-Term Follow-Up Protocol
Study ID: COG ALTE05N1
Disease: LTE (Late Effects)
Stage: N/A
  Learn More
Diabetes/Thyroid
Glycemic Control in DM1 Adolescents: Moderate-Intensity Exercise in Hot and Cool Environments
Study ID: Bergeron 03-10-007 HEAT
Disease:
Stage: Unknown
  Learn More
Natural History Study of The Development of Type 1 Diabetes
Study ID: TrialNet TN-01
Disease: Pancreas
Stage: Unknown
  Learn More
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Study ID: TrialNet TN-07
Disease: Pancreas
Stage: Unknown
  Learn More
Heart
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy in Patients with Clinically Evident Cardiovascular Disease
Study ID: Amgen FOURIER 20110118
Disease: Heart
Stage: Phase III
  Learn More
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Study ID: NHLBI ISCHEMIA NCT01471522
Disease: Heart
Stage: N/A
  Learn More
Randomized, single center study to determine if a cardiac rehabilitation program immediately following hospitalization reduces hospital readmissions and improves quality of life outcomes in heart failure patients.
Study ID: SH Cardiac Rehab
Disease:
Stage: N/A
  Learn More
A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Study ID: Abbott 10-392 Absorb III
Disease: Heart
Stage: N/A
  Learn More
JOSTENT Graft Master Coronary Stent Graft and Delivery System - A Humanitarian Use Device for use in the treatment of free perforations, defined as free contrast extravasations into the pericardium, in native vessels or saphenous vein bypass grafts greater than or equal to 2.75mm in diameter.
Study ID: Abbott JOSTENT GraftMaster
Disease: Heart
Stage: HDE
  Learn More
A Double-Blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of Evolocumab (AMG 145) on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subjects Undergoing Coronary Catheterization
Study ID: Amgen GLAGOV 20120153 IVUS
Disease: Heart
Stage: Phase III
  Learn More
Lead study
Study ID: Biotronik SIELLO Lead Study
Disease: Heart
Stage: IDE
  Learn More
A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass
Study ID: Grifols Antithrombin
Disease: Heart
Stage: Unknown
  Learn More
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
Study ID: Sanofi Odyssey Outcomes Study
Disease: Heart
Stage: Phase IIIB
  Learn More
cognitive function testing
Study ID: SH Cognitive Functioning Improves Following TAVI
Disease: Heart
Stage: Unknown
  Learn More
A PHASE IIa, DOUBLE-BLINDED, PLACEBO-CONTROLLED,MULTI-CENTER, RANDOMIZED STUDY TO ASSESS THE SAFETY,TOLERABILITY, AND PRELIMINARY EFFICACY OF A SINGLE INTRAVENOUS DOSE OF ALLOGENEIC MESENCHYMAL BONE MARROW CELLS TO SUBJECTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Study ID: Stemedica STEM 103-M-STEMI
Disease:
Stage: Phase IIA
  Learn More
Infectious Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-6072 (Human Monoclonal Antibody to Clostridium difficile toxin B) and MK-3415A (Human Monoclonal Antibodies to Clostridium difficile toxin A and toxin B) in Patients Receiving Antibiotic Therapy for Clostridium difficile Infection
Study ID: Merck MODIFY II MK-3415A
Disease:
Stage: Phase III
  Learn More
AC-061A301(302): Actelion Pharmaceuticals: A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid versus Vancomycin in Subjects with Clostridium difficile Associated Diarrhea (CDAD)
Study ID: PPD Actelion AC-061A301(302) C.diff
Disease:
Stage: Phase III
  Learn More
Protocol H-030-014 is a planned Phase III Study of C. difficile vaccine in participants at risk for C. difficile Infection = 50 years of age.
Study ID: Sanofi Pasteur H-030-014 C Diff Vaccine
Disease:
Stage: Phase III
  Learn More
Interventional Radiology
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System Study
Study ID: Cordis Open Clinical Study
Disease:
Stage: IDE
  Learn More
ACE: An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System
Study ID: Penumbra CLP 4492 ACE
Disease:
Stage: Post Marketing
  Learn More
Nephrology
Enterra HDE Therapy System
Study ID: Medtronic Enterra H990014
Disease:
Stage: HDE
  Learn More
Neurology
SH_Gene Discovery in Inherited Neurological Disease
Study ID: SH Gene Discovery in Inherited Neurological Disease
Disease:
Stage: Unknown
  Learn More
A Prospective Registry Study in a Global Huntingtons Disease Cohort A CHDI Foundation Project
Study ID: CHDI Enroll HD
Disease:
Stage: Registry
  Learn More
Investigating the neural mechanisms of working memory using transcranial magnetic stimulation and electroencephalographic recording in healthy subjects
Study ID: NDSU Jeff Johnson MRI Psychology Study
Disease:
Stage: N/A
  Learn More
Dystonia Coalition Projects
Study ID: NIH DCP 6301
Disease:
Stage: Registry
  Learn More
TRANSITION: A two-year observational study to evaluate the safety profile of fingolimod in patients with multiple sclerosis who switch from natalizumab to fingolimod
Study ID: Novartis CFTY720D2405 TRANSITION
Disease:
Stage: N/A
  Learn More
Identifying novel causes of encephalopathy
Study ID: SH Identifying novel causes of encephalopathy
Disease:
Stage: Unknown
  Learn More
Treatment of progressive forms of Multiple Sclerosis with pulsed ACTH (Acthar gel)
Study ID: U of M ACTH Study
Disease:
Stage: Unknown
  Learn More
Orthopedics
Endoscopic Decompression Compared to Open In Situ Release for the Treatment of Cubital Tunnel Syndrome (CuTS)
Study ID: SH Cubital Tunnel Study CuTS
Disease:
Stage: N/A
  Learn More
Vascular
A Phase II Clinical Study of the Safety and Performance of the Treovance Stent-Graft with Navitel Delivery System for Patients with Infrarenal Abdominal Aortic Aneurysms
Study ID: Bolton Medical IP-0008-12 Treovance Stent Graft
Disease:
Stage: Phase II
  Learn More
Prospective, Randomized, Multi-Center, Single-Blind Study for the Treatment of Subjects Presenting with De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using a Paclitaxel-Coated or Bare Percutaneous Transluminal Angioplasty Balloon Catheter
Study ID: Covidien ILLUMENATE-US
Disease:
Stage: Unknown
  Learn More
The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem Post Approval Study (DURABILITY PAS)
Study ID: EV3 Durablilty PAS CP-1001
Disease:
Stage: Post Marketing
  Learn More
Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (GORE IBE Device) for the Treatment of Common Illiac Artery Aneurysms (CIAA) and Aortic-iliac Aneurysms
Study ID: WL GORE® EXCLUDER® IBE 12-04
Disease:
Stage: IDE
  Learn More
Women's Health
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence
Study ID: Cook Myosite Inc Stress Urinary Incontinence 13-003
Disease:
Stage: Unknown
  Learn More
Prospective Data Collection for the Purpose of Creating a Database for Ongoing Patients Evaluated at the Sanford Fetal Care Center
Study ID: SH Sanford Fetal Care Center Database
Disease:
Stage: N/A
  Learn More
Other
Targeting ACE2/Angiotension-(1-7)/Mas axis to enhance vasoreparative function of endothelial progenitor cells in diabetes
Study ID: NDSU Vasoreparative Function Study
Disease:
Stage: N/A
  Learn More
The Sanford Health BioBank
Study ID: SH BioBank
Disease:
Stage: Unknown
  Learn More
Genetic Studies of Reproductive Disorders
Study ID: Medical College of Georgia GEORGIA
Disease:
Stage: Unknown
  Learn More